Table 6.
In vitro anti-HIV-1 activity of d-3′-F-C-d4G against wild type (WT) and M184V virus in human PBM cells using carbovir as positive control and correlation with calculated energy of complex (Inhibitor-TP) / HIV-RT after molecular dynamics simulations.
| Compound | xxBRU (WT) | M184V | FIb | ΔErelc | ||
|---|---|---|---|---|---|---|
| EC50 (μM) |
Erela (Kcal/mol) |
EC50 (μM) |
Erela (Kcal/mol) |
|||
| d-3′-F-C-d4G 35 | 0.098 | -270.2d | 3.8 | 84.9d | 38.8 | -355.1d |
| Carbovir | 0.087 | -310.0d | 0.20 | -63.4d | 2.3 | -246.6d |
Erel = (Binding energy of inhibitor-TP) – (Binding energy of natural 2′-dNTP)
FI is the Fold Increase (EC50 HIV-1M184V / EC50 HIV-1xxBRU).
ΔErel = Erel (WT) – Erel (M184V).
These values were calculated based on the molecular dynamics results (refer to experimental section)